JUXTAPID

LIVE

Serial Number

85980934

Owner

Aegerion Pharmaceuticals, Inc.

Attorney

Richard Todd Armstrong, Ph.D.

First Use Date

Jan 28, 2013

Filing Date

Dec 14, 2012

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

JUXTAPID Trademark

Serial Number: 85980934 • Registration: 4508190

JUXTAPID is a trademark filed by Aegerion Pharmaceuticals, Inc. on December 14, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Aegerion Pharmaceuticals, Inc. (33 trademarks)

Centerpointe IV, 1140 Route 22 East
Bridgewater, NJ 08807

Entity Type: 03

AMRYT PHARMACEUTICALS INC. (11 trademarks)

45 MESPIL ROAD
DUBLIN 4 , IE

Entity Type: 03

Legal Representation

Attorney of Record

Richard Todd Armstrong, Ph.D.

49 trademarks filed View all →

Correspondence Address

Richard Todd Armstrong, Ph.D. CLARK + ELBING LLP

101 FEDERAL ST FL 15

BOSTON, MA 02110-1817

United States

Trademark Details

Filing Date

December 14, 2012

Registration Date

April 1, 2014

First Use Anywhere

January 28, 2013

First Use in Commerce

January 28, 2013

Published for Opposition

May 14, 2013

Goods & Services

PHARMACEUTICALS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, IN PARTICULAR, HYPERLIPIDEMIA

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Dec 13, 2024 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Dec 13, 2024 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Dec 13, 2024 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Dec 13, 2024 APRE

TEAS SECTION 8 & 9 RECEIVED

Sep 5, 2024 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Apr 1, 2023 REM2

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 23, 2021 ASGN

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

May 2, 2020 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

May 2, 2020 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

May 2, 2020 APRE

TEAS SECTION 8 & 15 RECEIVED

Mar 10, 2020 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Apr 1, 2019 REM1

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Apr 18, 2018 ASCK

REGISTERED-PRINCIPAL REGISTER

Apr 1, 2014 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 25, 2014 SUNA

LAW OFFICE REGISTRATION REVIEW COMPLETED

Feb 24, 2014 REGV

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 24, 2014 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 11, 2014 SUPC

DIVISIONAL PROCESSING COMPLETE

Feb 11, 2014 DPCC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 9, 2014 AITU

USE AMENDMENT FILED

Jan 9, 2014 IUAF

SOU TEAS EXTENSION RECEIVED

Jan 9, 2014 EEXT

DIVISIONAL REQUEST RECEIVED

Dec 17, 2013 DRRR

TEAS REQUEST TO DIVIDE RECEIVED

Dec 17, 2013 ERTD

TEAS STATEMENT OF USE RECEIVED

Dec 17, 2013 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 9, 2013 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 14, 2013 NPUB

PUBLISHED FOR OPPOSITION

May 14, 2013 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 24, 2013 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 6, 2013 PREV

ASSIGNED TO LIE

Apr 3, 2013 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 30, 2013 CNSA

ASSIGNED TO EXAMINER

Mar 30, 2013 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 2, 2013 NWOS

NEW APPLICATION ENTERED

Dec 18, 2012 NWAP

Related Trademarks

More from this Owner

JUXTAPID

NOVELION THERAPEUTICS

More in Same Class